<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35378353</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2590-0412</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Respiratory medicine and research</Title><ISOAbbreviation>Respir Med Res</ISOAbbreviation></Journal><ArticleTitle>Proposals from a French expert panel for respiratory care in ALS patients.</ArticleTitle><Pagination><StartPage>100901</StartPage><MedlinePgn>100901</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resmer.2022.100901</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2590-0412(22)00018-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive diaphragm weakness and deteriorating lung function. Bulbar involvement and cough weakness contribute to respiratory morbidity and mortality. ALS-related respiratory failure significantly affects quality of life and is the leading cause of death. Non-invasive ventilation (NIV), which is the main recognized treatment for alleviating the symptoms of respiratory failure, prolongs survival and improves quality of life. However, the optimal timing for the initiation of NIV is still a matter of debate. NIV is a complex intervention. Multiple factors influence the efficacy of NIV and patient adherence. The aim of this work was to develop practical evidence-based advices to standardize the respiratory care of ALS patients in French tertiary care centres.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">For each proposal, a French expert panel systematically searched an indexed bibliography and prepared a written literature review that was then shared and discussed. A combined draft was prepared by the chairman for further discussion. All of the proposals were unanimously approved by the expert panel.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The French expert panel updated the criteria for initiating NIV in ALS patients. The most recent criteria were established in 2005. Practical advice for NIV initiation were included and the value of each tool available for NIV monitoring was reviewed. A strategy to optimize NIV parameters was suggested. Revisions were also suggested for the use of mechanically assisted cough devices in ALS patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our French expert panel proposes an evidence-based review to update the respiratory care recommendations for ALS patients in daily practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Masson SAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georges</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Diseases and Intensive Care, Reference Center for Adult Rare Pulmonary Diseases, University Hospital of Dijon-Bourgogne, Dijon, France; University of Bourgogne Franche-Comt&#xe9;, Dijon France; Centre des Sciences du Go&#xfb;t et de l'Alimentation, UMR 6265 CNRS 1234 INRA, University of Bourgogne Franche-Comt&#xe9;, Dijon, France. Electronic address: marjolaine.georges@chu-dijon.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory Diseases, University Hospital of Lille, Lille, France; Centre for Infection and Immunity of Lille, INSERM U1019-UMR9017, University of Lille Nord de France, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabec</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory Diseases and Intensive Care, Reference Center for Adult Rare Pulmonary Diseases, University Hospital of Dijon-Bourgogne, Dijon, France; University of Bourgogne Franche-Comt&#xe9;, Dijon France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacquin</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Training Manager for ResMed SAS company, Saint-Priest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finet-Monnier</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Disorders and ALS, University Hospital of Timone, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CRMR SLA-MNM, H&#xf4;pital Pasteur 2, University Hospital of Nice, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patout</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service des Pathologies du Sommeil (D&#xe9;partement R3S), Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, AP-HP, Paris, France; Neurophysiologie Respiratoire Exp&#xe9;rimentale et Clinique, INSERM UMRS1158, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attali</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Service des Pathologies du Sommeil (D&#xe9;partement R3S), Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, AP-HP, Paris, France; Neurophysiologie Respiratoire Exp&#xe9;rimentale et Clinique, INSERM UMRS1158, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amador</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Department, Paris ALS center, Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Bermejo</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurophysiologie Respiratoire Exp&#xe9;rimentale et Clinique, INSERM UMRS1158, Sorbonne Universit&#xe9;, Paris, France; Service de Pneumologie (D&#xe9;partement R3S), Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salachas</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurology Department, Paris ALS center, Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelot-Panzini</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurophysiologie Respiratoire Exp&#xe9;rimentale et Clinique, INSERM UMRS1158, Sorbonne Universit&#xe9;, Paris, France; Service de Pneumologie (D&#xe9;partement R3S), Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017065">Practice Guideline</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Respir Med Res</MedlineTA><NlmUniqueID>101746324</NlmUniqueID><ISSNLinking>2590-0412</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Capnography</Keyword><Keyword MajorTopicYN="N">Mechanical insufflation-exsufflation</Keyword><Keyword MajorTopicYN="N">Monitoring</Keyword><Keyword MajorTopicYN="N">Noninvasive ventilation</Keyword><Keyword MajorTopicYN="N">Palliative</Keyword><Keyword MajorTopicYN="N">Vital capacity</Keyword></KeywordList><CoiStatement>Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35378353</ArticleId><ArticleId IdType="doi">10.1016/j.resmer.2022.100901</ArticleId><ArticleId IdType="pii">S2590-0412(22)00018-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>